JP2010502585A5 - - Google Patents

Download PDF

Info

Publication number
JP2010502585A5
JP2010502585A5 JP2009526190A JP2009526190A JP2010502585A5 JP 2010502585 A5 JP2010502585 A5 JP 2010502585A5 JP 2009526190 A JP2009526190 A JP 2009526190A JP 2009526190 A JP2009526190 A JP 2009526190A JP 2010502585 A5 JP2010502585 A5 JP 2010502585A5
Authority
JP
Japan
Prior art keywords
compound
amino acid
acid residue
compound according
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009526190A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010502585A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2007/002479 external-priority patent/WO2008026040A2/en
Publication of JP2010502585A publication Critical patent/JP2010502585A/ja
Publication of JP2010502585A5 publication Critical patent/JP2010502585A5/ja
Pending legal-status Critical Current

Links

JP2009526190A 2006-08-28 2007-08-28 68Ga標識ペプチド系放射性医薬品 Pending JP2010502585A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82368206P 2006-08-28 2006-08-28
PCT/IB2007/002479 WO2008026040A2 (en) 2006-08-28 2007-08-28 68ga-labeled peptide-based radiopharmaceuticals

Publications (2)

Publication Number Publication Date
JP2010502585A JP2010502585A (ja) 2010-01-28
JP2010502585A5 true JP2010502585A5 (OSRAM) 2011-09-15

Family

ID=38961954

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009526190A Pending JP2010502585A (ja) 2006-08-28 2007-08-28 68Ga標識ペプチド系放射性医薬品

Country Status (5)

Country Link
US (1) US20100233082A1 (OSRAM)
EP (1) EP2056886A2 (OSRAM)
JP (1) JP2010502585A (OSRAM)
CN (1) CN101528270A (OSRAM)
WO (1) WO2008026040A2 (OSRAM)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2975841C (en) * 2008-04-30 2021-05-25 Siemens Medical Solutions Usa, Inc. Substrate based pet imaging agents
GB0814722D0 (en) * 2008-08-12 2008-09-17 Ge Healthcare Ltd Treatment monitoring
EP2468760B1 (en) * 2009-08-20 2014-10-01 Fujifilm RI Pharma Co., Ltd. Bisphosphonic acid derivative and compound thereof labeled with radioactive metal nuclide
ITFI20110180A1 (it) * 2011-08-12 2013-02-13 Advanced Accelerator Applic S A Processo per la preparazione di complessi di 68ga.
PL3590542T3 (pl) * 2012-12-03 2024-05-13 Curasight A/S Peptydy znakowane radionuklidem emitującym pozytony do obrazowania upar metodą pet u ludzi
GB201511036D0 (en) * 2015-06-23 2015-08-05 Guy S And St Thomas Hospital Nhs Foundation Trust Imaging method
JP2020506921A (ja) * 2017-01-30 2020-03-05 ヴェクト−オールVect−Horus がんイメージング及びがん放射線治療のための組成物及び方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1272507E (pt) * 2000-04-12 2005-11-30 Amersham Health As Derivados de peptidos para ligacao a integrina
NO20004795D0 (no) * 2000-09-26 2000-09-26 Nycomed Imaging As Peptidbaserte forbindelser
EP2347771A1 (en) * 2001-07-10 2011-07-27 Ge Healthcare As Peptide-based compounds for targeted imaging
GB0308408D0 (en) * 2003-04-11 2003-05-21 Amersham Plc Microwave activation
US8182790B2 (en) * 2004-11-22 2012-05-22 Ge Healthcare As Contrast agents
GB0428012D0 (en) * 2004-12-22 2005-01-26 Hammersmith Imanet Ltd Radiolabelling methods

Similar Documents

Publication Publication Date Title
JP2010502585A5 (OSRAM)
RU2441668C2 (ru) Новые визуализирующие агенты
RU2451029C2 (ru) Производное инсулина
CA2452923A1 (en) Peptide-based compounds for targeting integrin receptors
RU2470016C2 (ru) Производное бипиразола
JP2018518537A5 (OSRAM)
CA2405469A1 (en) Integrin binding peptide derivatives
JP2010523599A5 (OSRAM)
SG149895A1 (en) Contrast agents for myocardial perfusion imaging
CA2533321A1 (en) Bicyclic peptide imaging agents
JP2009537624A5 (OSRAM)
JP2016527277A5 (OSRAM)
JP2008528658A5 (OSRAM)
RU2014112319A (ru) Соединения и фармацевтические композиции для лечения вирусных инфекций
EA200970287A1 (ru) Способы, соединения, композиции и носители, подходящие для доставки 3-амино-1-пропансульфоновой кислоты
JP2020507589A5 (OSRAM)
JP2008201787A5 (OSRAM)
EP2253333A3 (en) Contrast Agents for Myocardial Perfusion Imaging
JP2009541288A5 (OSRAM)
JP2011520931A (ja) {f−19}標識l−グルタミン酸及びl−グルタミン誘導体(iii)、それらの使用並びにそれらを得る方法
RU2012124266A (ru) Хелаты марганца и их применение в качестве контрастных агентов в магнитно-резонансной визуализации (mpb)
JP2010505865A5 (OSRAM)
JP2012504131A5 (OSRAM)
JP2008504237A5 (OSRAM)
RU2006144279A (ru) Пептидные соединения